Literature DB >> 2460554

Suppressor T cells regulating the cell-mediated immune response to Pseudomonas aeruginosa can be generated by immunization with anti-bacterial T cells.

R B Markham1, G B Pier, W G Powderly.   

Abstract

We previously demonstrated that immunization with low (10 micrograms) doses of high m.w. polysaccharide from the gram-negative bacterium Pseudomonas aeruginosa generates T cells that suppress the ability of antibacterial T cells (Tab) to protect against bacterial infection. The current studies indicate that Ts cells with properties identical to those elicited by low dose polysaccharide immunization can be generated by immunization with Tab. Tab-elicited Ts cells can abrogate in vivo induction and in vitro and in vivo expression of antibacterial T cell activity. Tab-elicited Ts are Ag-specific and H-2 restricted in their suppressor activity. Non-immune T cells fail to elicit suppressor activity. These studies provide additional evidence that the protective T cell response to P. aeruginosa is controlled by a network of T cells that are probably recognizing idiotypic determinants on P. aeruginosa-immune T and B cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460554

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells.

Authors:  B J Shenker; L A Vitale; D A Welham
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.

Authors:  Gregory P Priebe; Mary M Brinig; Kazue Hatano; Martha Grout; Fadie T Coleman; Gerald B Pier; Joanna B Goldberg
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.

Authors:  Gregory P Priebe; Gloria J Meluleni; Fadie T Coleman; Joanna B Goldberg; Gerald B Pier
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

4.  Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response.

Authors:  C Moser; P O Jensen; O Kobayashi; H P Hougen; Z Song; J Rygaard; A Kharazmi; N H by
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

5.  Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide.

Authors:  C V Garner; D DesJardins; G B Pier
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.

Authors:  G B Pier; S Takeda; M Grout; R B Markham
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.